United States · FDA National Drug Code directory
Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-146_6847f060-0180-4f7e-aba8-4dce8c53e7ae
- Product NDC
- 50228-146
- Form
- CAPSULE
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- ScieGen Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190114
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (50228-146-01) · 50228-146-01
- 500 CAPSULE in 1 BOTTLE (50228-146-05) · 50228-146-05
- 1000 CAPSULE in 1 BOTTLE (50228-146-10) · 50228-146-10
- 30 CAPSULE in 1 BOTTLE (50228-146-30) · 50228-146-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →